Press release
BCL B Cell Lymphoma Inhibitors Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
BCL B cell lymphoma inhibitors market is anticipated to grow at a significant CAGR during the forecast period. BCL-2, also known as B Cell Lymphoma 2, is a protein-encoding gene belonging to the B cell lymphoma family. The market growth is majorly attributable to the growth in the prevalence of diffuse B cell lymphoma, a common type of non-Hodgkin lymphoma. For instance, according to an article by Lymphoma Research Foundation in 2019, in the US, DLBCL accounted for 22% of newly diagnosed B cell lymphoma cases. Around 18,000 people globally are diagnosed with DLBCL each year.Adding to this, the disease affects people over 60 years of age. According to the American Cancer Society in 2019, an estimated 20,720 people were diagnosed with chronic lymphocytic lymphoma. Moreover, 90% of the people diagnosed with this form of lymphoma are estimated to affect people above 50 years of age. In the US, 2,220 men and 1,710 women are expected to be suffering from chronic lymphocytic lymphoma every year. Moreover, as per the American Cancer Society, about 3,930 mortalities were anticipated to take place in 2019.
Further, there are various inhibitor drugs being approved in the market that spur market growth. For instance, Venetoclax is the only and first approved FDA BCL-2 inhibitor drug for chronic lymphocytic lymphoma patients. Although various clinical trials are being carried out for the development of new BCL-2 inhibitors.
Some key players operating in the market include AbbVie, Roche, Abcam, Biorbyt, Biovison, and Tocris Bioscience. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
To Request a Sample of our Report on BCL B Cell Lymphoma Inhibitors Market: https://www.omrglobal.com/request-sample/bcl-b-cell-lymphoma-inhibitors-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered
Regions Covered- Globally
Competitive Landscape: AbbVie, Roche, Abcam, Biorbyt, Biovison, and Tocris Bioscience
A full Report of BCL B Cell Lymphoma Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/bcl-b-cell-lymphoma-inhibitors-market
BCL B Cell Lymphoma Inhibitors Market - Segmentation
By Therapy
Monotherapy
Combination Therapy
By Type
Positive Lymphoma
Follicular Lymphoma
BCL B Cell Lymphoma Inhibitors Market Segmentation by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BCL B Cell Lymphoma Inhibitors Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 3320724 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for BCL
BCL-2 Family ELISA Kits Market Outlook and Future Projections for 2030
The bcl-2 family elisa kits market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Rice Bran Oil Market Seeking Excellent Growth | Ricela, BCL Industries, Cargill, …
HTF MI just released the Global Rice Bran Oil Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Rice Bran Oil Market are: Ricela,…
BCL B Cell Lymphoma Inhibitors Market: A Comprehensive Overview
The global BCL B Cell Lymphoma Inhibitors market was valued aapproximately $3.03 billion in 2023 and is projected to reach around $4.90 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.7% during the forecast period.
BCL B Cell Lymphoma Inhibitors Market Overview
Allergic conjunctivitis, an inflammation of the conjunctiva due to allergen exposure, leads to symptoms such as redness, itching, and tearing. The market's growth is driven…
BCL-2-Like Protein Market Will Generate Record Revenue by 2029
BCL-2-Like Protein Market is anticipated to grow at a significant CAGR during the forecast period. BCL-2, also known as B Cell Lymphoma 2, is a protein encoding gene belonging to the B cell lymphoma family. The market growth is majorly attributable to the growth is the significant prevalence of diffuse B cell lymphoma, a common type of non-Hodgkin lymphoma. For instance, according to an article by Lymphoma Research Foundation in…
BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on BCL-2 (B-cell lymphoma 2) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the BCL-2 (B-cell lymphoma 2) Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$…
Global Rice Bran Oil Market 2017 - Ricela, Kamal, BCL, Vaighai, SVROil
Rice Bran Oil Market report focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer. Additionally, the region-wise segmentation and the trends driving the leading geographical region and the emerging region has been presented in this report.
Download Sample Report @ http://www.fiormarkets.com/report-detail/55972/request-sample
Global Rice Bran Oil Industry 2017 is an analytical research report that delves into the dynamics of the global Rice Bran Oil industry.…